Prosecution Insights
Last updated: August 17, 2026

Examiner: CHERNYSHEV, OLGA N

Tech Center 1600 • Art Units: 1600 1649 1674 1675

This examiner grants 54% of resolved cases

Performance Statistics

54.5%
Allow Rate
-5.5% vs TC avg
998
Total Applications
+34.2%
Interview Lift
1085
Avg Prosecution Days
Based on 956 resolved cases, 2023–2026

Rejection Statute Breakdown

15.8%
§101 Eligibility
11.5%
§102 Novelty
8.5%
§103 Obviousness
47.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18147360 METHODS OF DIAGNOSING BRAIN INJURY Final Rejection Abbott Laboratories
17747397 METHODS OF EVALUATING BRAIN INJURY IN A PEDIATRIC SUBJECT Non-Final OA Abbott Laboratories
17914121 COMPOSITIONS AND METHODS FOR TREATING A NEURODEGENERATIVE OR DEVELOPMENTAL DISORDER Final Rejection The Regents of the University of California
18027589 METHODS, COMPOSITIONS, AND KITS FOR DETECTING AND MEASURING ENDOTHELIAL INJURY IN NORMAL AND DISEASED HUMAN CENTRAL NERVOUS SYSTEM (CNS) Non-Final OA Ohio State Innovation Foundation
17980435 BLOOD-BASED SCREEN FOR DETECTING NEUROLOGICAL DISEASES IN PRIMARY CARE SETTINGS Non-Final OA Board of Regents, The University of Texas System
18028932 PEPTIDE FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Final Rejection SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
17996498 PROTEIN MARKERS FOR ASSESSING ALZHEIMER'S DISEASE Final Rejection The Hong Kong University of Science and Technology

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month